Loading organizations...

Rayvio is a technology company.
RayVio Corp. develops advanced ultraviolet (UV) LED technology, offering compact, energy-efficient, and mercury-free light sources. These solutions enable chemical-free disinfection of water, air, and surfaces, along with applications in industrial curing and medical fields. The company provides versatile, on-demand hygiene solutions.
Founded in 2012 by Dr. Yitao Liao, Professor Theodore Moustakas, Robert C. Walker, and Milan Minsky, RayVio originated from Boston University research. Their collective insight was to leverage solid-state lighting principles for the UV spectrum, creating novel applications. Dr. Liao pioneered the core technology, while Professor Moustakas brought deep expertise from his work in blue LEDs.
RayVio's technology serves diverse industrial and consumer markets, providing effective health and hygiene solutions. The company aims to protect individuals from germs by enabling clean environments through its powerful UV LED integration into various products. Their vision centers on empowering consumers with enhanced sanitation through advanced light-based solutions.
Rayvio has raised $40.0M across 3 funding rounds.
Rayvio has raised $40.0M in total across 3 funding rounds.
RayVio is an advanced health and hygiene technology company specializing in powerful, compact ultraviolet (UV) LED technology for disinfection.[1][2] It develops UV LEDs that deactivate pathogens by damaging their DNA, enabling chemical-free solutions like point-of-use water disinfection, self-disinfecting bottles, and hospital surface cleaners, primarily serving OEM partners, industrial applications, and consumer product makers.[1][2] The technology targets bacteria, viruses, and other germs in water and environments, with products among the smallest commercially available (6.5 mm width, up to 40 milliwatts power at 280-290 nm wavelength).[1] RayVio, a Boston University spin-out based in Hayward, California, raised $26 million in 2016 to scale manufacturing, expand capacity, double its workforce, and advance R&D, demonstrating strong early growth momentum.[1][2]
RayVio emerged from Boston University research, founded by Yitao Liao, a former doctoral candidate in the lab of Professor Theodore Moustakas, a pioneer in blue LED technology.[2] Liao co-developed the core UV LED innovation, which absorbs into microbial DNA/RNA/proteins to trigger photochemical reactions that break chemical bonds and halt reproduction—offering a smaller, more reliable, toxin-free alternative to mercury lamps.[2] With BU Technology Development support, Liao secured patents, raised funds, and launched RayVio about a year post-graduation to commercialize the breakthrough.[2] By 2016, the company had relocated to Hayward, California, raised $26 million for manufacturing expansion via the city's Business Concierge Program, and built early traction with OEM partners integrating the tech into health and hygiene products.[1]
(Note: Search result [3] incorrectly describes RayVio as an online slot game provider, which conflicts with primary sources and is disregarded as inaccurate.[1][2])
RayVio rides the wave of UV LED adoption for pathogen mitigation, accelerated by post-pandemic demand for chemical-free disinfection in health, water purification, and workplace safety.[1][2][4] Its timing aligns with global needs to protect billions from germs amid rising hygiene awareness, enabling markets like automated risk management and OEM-integrated products.[1][4] Favorable forces include advancements in LED materials (building on blue LED legacies) and regulatory pushes against mercury lamps, positioning RayVio to influence ecosystems from consumer goods to hospitals by powering scalable, portable solutions.[2] As a university spin-out, it exemplifies academic tech transfer driving practical impact in hygiene tech.[2]
RayVio's trajectory points to expanded adoption in smart hygiene devices, water tech, and IoT-enabled disinfection as UV LEDs mature and costs drop.[1][2] Trends like AI-driven pathogen monitoring and sustainable alternatives to chemicals will amplify its edge, potentially growing via partnerships and new wavelengths.[1] Its influence may evolve from niche innovator to ecosystem enabler, scaling manufacturing to meet demand and solidifying leadership in germ-free environments—echoing its founding promise to deliver clean water and spaces for billions.[1][2]
Rayvio has raised $40.0M in total across 3 funding rounds.
Rayvio's investors include Alex Banh, Don Ye, Alpha Edison, Applied Ventures, Trinity Ventures, Janice Roberts, Tom Blaisdell, Augment Ventures, Capricorn Investment Group, DCM, New Ground Ventures, Tolero Ventures.
Rayvio has raised $40.0M across 3 funding rounds. Most recently, it raised $26.0M Series B in April 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2016 | $26.0M Series B | Alex Banh, Don Ye | Alpha Edison, Applied Ventures, Trinity Ventures, Janice Roberts, Tom Blaisdell, Augment Ventures, Capricorn Investment Group, DCM, New Ground Ventures, Tolero Ventures |
| Mar 1, 2015 | $9.0M Series B | Alpha Edison, Applied Ventures, Trinity Ventures, Janice Roberts, Tom Blaisdell, Augment Ventures, Capricorn Investment Group, Peter Moran, New Ground Ventures, Tolero Ventures | |
| Jun 1, 2012 | $5.0M Series A | Alpha Edison, Trinity Ventures, Janice Roberts, Tom Blaisdell |